🇺🇸 FDA
Pipeline program

HTX-011

HTX-011-301

Approved small_molecule completed

Quick answer

HTX-011 for Postoperative Pain is a Approved program (small_molecule) at HERON THERAPEUTICS, INC. /DE/ with 8 ClinicalTrials.gov record(s).

Program details

Company
HERON THERAPEUTICS, INC. /DE/
Indication
Postoperative Pain
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials